PYC Therapeutics Limited
ASX:PYC.AX
Overview | Financials
Company Name | PYC Therapeutics Limited |
Symbol | PYC.AX |
Currency | AUD |
Price | 0.145 |
Market Cap | 603,716,860 |
Dividend Yield | 0% |
52-week-range | 0.052 - 0.15 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Rohan Hockings G.D.L.P, J.D., MBBS, MBBS (Hons.) |
Website | https://pyctx.com |
An error occurred while fetching data.
About PYC Therapeutics Limited
PYC Therapeutics Limited, a drug-development company, engages in the discovery and development of drug solutions in the areas of ribonucleic acid therapeutics in Australia. The company's preclinical development programs include VP-001, drug program for retinitis pigmentosa type 11; and PYC-001, a drug program for the treatment of autosomal dominant optic
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD